UF Health Cancer Institute scientists found a bacterial compound that may double lung cancer treatment effectiveness in mice.

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

LUNGevity Foundation, the nation's leading lung cancer–focused nonprofit organization, is now accepting applications for their 2026 research grants. These competitive awards are designed to accelerate ...

A team of scientists from the United Kingdom has developed a new blood test that could change the way lung cancer is detected and monitored. A new study talks about using the Fourier Transform ...

A Sri Lankan-born scientist has made waves in the global medical community with groundbreaking research that could ...

A research team led by Dr. Juyeon Jung at the Bio-Nano Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), has developed a nanobody-based technology that can precisely ...

Lung cancer incidence rates in the United States have undergone a significant transformation over the last several decades, ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...